Guidelines on how innovators can assert patents to protect their products’ exclusivity while avoiding claims from competitors and the FTC that their conduct runs afoul of U.S. antitrust law.
Michael Dougherty
Advertisement
Articles by Michael Dougherty
Advertisement
Latest Updated Articles
- Preparing for Competitive Challenges to Biologics with Expiring Market Exclusivity
Published: January 31st 2020 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings
2
FDA Announces New Biosimilar-Targeted Draft Guidance
3
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
4
Lilly Forms Partnership with NVIDIA to Create AI Supercomputer
5
